drugset / Trial / NCT03944447
Outcomes Mandate National Integration With Cannabis as Medicine
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Timeline
- Start
- 2018-12-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabis, Medical | Unknown | — | — |
Indications
COVID-19
Crohn disease
HIV infectious disease
Parkinson disease
Tourette syndrome
amyotrophic lateral sclerosis
anxiety
autism
bipolar disorder
cancer
depressive disorder
epilepsy
fibromyalgia
glaucoma
hepatitis C virus infection
insomnia
multiple sclerosis
post-traumatic stress disorder
sickle cell disease
substance-related disorder
traumatic brain injury
traumatic encephalopathy
ulcerative colitis